Company profile
Allozyne company profile
Allozyne develops and commercializes technologies that enable improvements in the efficacy, safety, dosing, and other characteristics of protein-based therapeutics, including peptides, antibodies, and vaccines. Its PEGylated IFN beta is for the treatment of multiple sclerosis. The company was founded in 2005 and is based in Seattle, Washington.
Business identity
- Website
- http://www.allozyne.com
- Contact email
- [email protected]
- Phone number
- 206-518-5700
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2005-01-01, Year
Headquarters
- Headquarters
- Seattle, Washington, United States
- Postal code
- 98102
- Country code
- US
- Continent
- North America